Polyphron
Platform using AI to simulate living human tissue for drug testing.
Polyphron is a biotech & life sciences company based in New York, US. It has raised $20 million in disclosed funding. Its latest round was a Seed of $20 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $20M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Polyphron do?
Platform using AI to simulate living human tissue for drug testing.
How much has Polyphron raised?
Polyphron has raised $20 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Polyphron?
Investors in Polyphron include Quiet Capital, Haystack, Gradient, and Compound.
When and where was Polyphron founded?
Polyphron and is based in New York, US.
Sources
- 1.Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Before Clinical Trials — AlleyWatch, Oct 9, 2026